ahlam1399
06-22-2016, 02:50 PM
Over Rs1 bn scam
ISLAMABAD: The National Accountability Bureau Rawalpindi has filed a corruption case in the Accountability Court against top officials of ***** Pricing Committee (DPC) for extended undue financial favours to pharma companies/ firms in the shape of illegal and unjustified price increase to their *****.
The NAB Rawalpindi filed the corruption reference against Arshad Farooq Faheem (The then Chairman ***** Pricing Committee) Additional Secretary (BPS-21), Wafaqi Mohtasib Secretariat , Dr. Muhammad Ali (The then Secretary cum Member ***** Pricing Committee) ex-Member Pricing (BPS-21) DRAP, Saleem Isharat Hussain (The then Member ***** Pricing Committee) Chief Drug Inspector (R), Health Department Government of Sindh, Ayaz Ali Khan, The then Member ***** Pricing Committee (Ex Chief ***** Controller Punjab) Chief Operating ******r Pakistan ***** Testing and Research Center, Lahore R/o 5-A, Faisal Town, Lahore, Sabir Ali (The then Member ***** Pricing Committee) Chief Drug Inspector (R) Health Department, Govt Khyber Pakhtunkhwa, Abdul Salam Mufti (The then Member ***** Pricing Committee) Chief Drug Inspector (R), Health Department Govt of Punjab, Sultan Ahmed (The then Member ***** Pricing Committee) Senior Drug Inspector, Health Department Govt of Balochistan , Rashid Latif Sheikh (The then Member ***** Pricing Committee) Ex-Director Cost Accounts Organisation, Ministry of Finance and seven pharmaceutical companies M/s Maple Pharmaceuticals (Pvt) Ltd, M/s Akhai Agencies, M/s Zam Zam Corporation, Excel Health Care Laboratories (Pvt) Ltd, M/s Saffron Pharmaceutical (Pvt) Ltd, M/s Galaxy Pharma (Pvt) Ltd M/s Martin Dow Ltd and others regarding drug pricing issues in Accountability Court Islamabad.
The members of the DPC in connivance with each others and beneficiary Pharma companies / firms extended undue financial favours to Pharma companies / firms in the shape of illegal and unjustified price increase to their ***** through DPC meeting held on 9-10-2012 & 22-01-2013 and subcommittee meeting held on 19-11-2012.
The wrongful financial benefits derived by the eight pharmaceutical companies / firms on the basis of price increase through above said meetings comes to be Rs1078.08 million till 30-6-2015 (out of which one Pharma company M/s RG Pharmaceutical (Pvt) Ltd returned an amount of Rs385.12 million through plea bargain after deducting retailer and distributor margin.
This illegal benefit is perpetually being gained by the pharmaceutical companies / firms who submitted inflated invoices / incorrect / incomplete costing data and were selling of their ***** on prices which were illegally increased by the members of DPC.
As per details, NAB received a complaint wherein it was alleged that ******rs / officials of Ministry of National Regulation & Health Services Division (NR&HSD) and others were involved in illegal increase in prices of ***** through ***** Pricing Committee meetings.
The prices of the ***** were fixed as per section 12 of ***** Act 1976 by ***** Pricing Committee (DPC) duly constituted by the Federal Govt.
During the process of investigation, it revealed that the pharmaceutical companies in connivance with accused ******rs/ officials submitted incomplete/incorrect and inflated invoices to DRAP for fixation of ***** prices at exorbitant rates.
Due to illegal price hike in the DPC meetings held on 9-10-2012 & 22-01-2013 and sub-committee meeting held on 19-11-2012 approximately Rs1078.08 million has been pocketed by these pharmaceutical companies causing unbearable burden on general public.
In this case two accused persons namely Tariq Haider and Mian M Khalid were arrested but released after payment of their liability through plea bargain.
So far NAB Rawalpindi recovered Rs385.11 million from accused persons namely Tariq Haider and Mian Khalid Mehmood Directors of M/S RG Pharmaceutical (Pvt) Ltd in the investigation against ******rs / officials of national regulations and services, beneficiaries and other regarding drug pricing issues through plea bargain whereas reference against accused persons for the remaining wrongful gain of Rs692.96 million has been filed in Accountability Court, Islamabad.
The NAB has recommended in this reference that the accused persons be punished in accordance with law and the ***** prices be reduced in the previous level so that general public may benefit from it as was done in the case of M/s RG Pharmaceutical Pvt Ltd.
Director General NAB Rawalpindi Zahir shah said NAB strongly believes in zero tolerance policy against corruption. NAB’s anti-corruption campaign is carried widely for awareness and prevention of corruption besides enforcement across the board. NAB hopes that joint efforts of all stakeholders can collaborate to check corruption and corrupt practices before happening with the help of all stakeholders.
He said the NAB ******rs/officials under the leadership of Chairman NAB Qamar Zaman Chaudary are determined and committed to perform their national duty with absolute objectivity, thorough professionalism, and unimpeachable integrity and without any leanings for or against anybody.
http://feeds.feedburner.com/~r/com/YEor/~4/mUp2CxQLlTw
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/mUp2CxQLlTw/129819-NAB-files-corruption-case-against-drugbody-members-pharmaceutical-companies)
ISLAMABAD: The National Accountability Bureau Rawalpindi has filed a corruption case in the Accountability Court against top officials of ***** Pricing Committee (DPC) for extended undue financial favours to pharma companies/ firms in the shape of illegal and unjustified price increase to their *****.
The NAB Rawalpindi filed the corruption reference against Arshad Farooq Faheem (The then Chairman ***** Pricing Committee) Additional Secretary (BPS-21), Wafaqi Mohtasib Secretariat , Dr. Muhammad Ali (The then Secretary cum Member ***** Pricing Committee) ex-Member Pricing (BPS-21) DRAP, Saleem Isharat Hussain (The then Member ***** Pricing Committee) Chief Drug Inspector (R), Health Department Government of Sindh, Ayaz Ali Khan, The then Member ***** Pricing Committee (Ex Chief ***** Controller Punjab) Chief Operating ******r Pakistan ***** Testing and Research Center, Lahore R/o 5-A, Faisal Town, Lahore, Sabir Ali (The then Member ***** Pricing Committee) Chief Drug Inspector (R) Health Department, Govt Khyber Pakhtunkhwa, Abdul Salam Mufti (The then Member ***** Pricing Committee) Chief Drug Inspector (R), Health Department Govt of Punjab, Sultan Ahmed (The then Member ***** Pricing Committee) Senior Drug Inspector, Health Department Govt of Balochistan , Rashid Latif Sheikh (The then Member ***** Pricing Committee) Ex-Director Cost Accounts Organisation, Ministry of Finance and seven pharmaceutical companies M/s Maple Pharmaceuticals (Pvt) Ltd, M/s Akhai Agencies, M/s Zam Zam Corporation, Excel Health Care Laboratories (Pvt) Ltd, M/s Saffron Pharmaceutical (Pvt) Ltd, M/s Galaxy Pharma (Pvt) Ltd M/s Martin Dow Ltd and others regarding drug pricing issues in Accountability Court Islamabad.
The members of the DPC in connivance with each others and beneficiary Pharma companies / firms extended undue financial favours to Pharma companies / firms in the shape of illegal and unjustified price increase to their ***** through DPC meeting held on 9-10-2012 & 22-01-2013 and subcommittee meeting held on 19-11-2012.
The wrongful financial benefits derived by the eight pharmaceutical companies / firms on the basis of price increase through above said meetings comes to be Rs1078.08 million till 30-6-2015 (out of which one Pharma company M/s RG Pharmaceutical (Pvt) Ltd returned an amount of Rs385.12 million through plea bargain after deducting retailer and distributor margin.
This illegal benefit is perpetually being gained by the pharmaceutical companies / firms who submitted inflated invoices / incorrect / incomplete costing data and were selling of their ***** on prices which were illegally increased by the members of DPC.
As per details, NAB received a complaint wherein it was alleged that ******rs / officials of Ministry of National Regulation & Health Services Division (NR&HSD) and others were involved in illegal increase in prices of ***** through ***** Pricing Committee meetings.
The prices of the ***** were fixed as per section 12 of ***** Act 1976 by ***** Pricing Committee (DPC) duly constituted by the Federal Govt.
During the process of investigation, it revealed that the pharmaceutical companies in connivance with accused ******rs/ officials submitted incomplete/incorrect and inflated invoices to DRAP for fixation of ***** prices at exorbitant rates.
Due to illegal price hike in the DPC meetings held on 9-10-2012 & 22-01-2013 and sub-committee meeting held on 19-11-2012 approximately Rs1078.08 million has been pocketed by these pharmaceutical companies causing unbearable burden on general public.
In this case two accused persons namely Tariq Haider and Mian M Khalid were arrested but released after payment of their liability through plea bargain.
So far NAB Rawalpindi recovered Rs385.11 million from accused persons namely Tariq Haider and Mian Khalid Mehmood Directors of M/S RG Pharmaceutical (Pvt) Ltd in the investigation against ******rs / officials of national regulations and services, beneficiaries and other regarding drug pricing issues through plea bargain whereas reference against accused persons for the remaining wrongful gain of Rs692.96 million has been filed in Accountability Court, Islamabad.
The NAB has recommended in this reference that the accused persons be punished in accordance with law and the ***** prices be reduced in the previous level so that general public may benefit from it as was done in the case of M/s RG Pharmaceutical Pvt Ltd.
Director General NAB Rawalpindi Zahir shah said NAB strongly believes in zero tolerance policy against corruption. NAB’s anti-corruption campaign is carried widely for awareness and prevention of corruption besides enforcement across the board. NAB hopes that joint efforts of all stakeholders can collaborate to check corruption and corrupt practices before happening with the help of all stakeholders.
He said the NAB ******rs/officials under the leadership of Chairman NAB Qamar Zaman Chaudary are determined and committed to perform their national duty with absolute objectivity, thorough professionalism, and unimpeachable integrity and without any leanings for or against anybody.
http://feeds.feedburner.com/~r/com/YEor/~4/mUp2CxQLlTw
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/mUp2CxQLlTw/129819-NAB-files-corruption-case-against-drugbody-members-pharmaceutical-companies)